23 assets in Brain Disorder

Therapeutic assets addressing Brain Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Donanemab Brain Disorder	Eli Lilly and Company	P3	B (62)
Fremanezumab Brain Disorder	Hospital Clínico Universitario de Valladolid	P4	B (62)
Live Combined Bifidobacterium Brain Disorder	Beijing Friendship Hospital	P4	B (62)
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules Brain Disorder	Beijing Friendship Hospital	P4	B (62)
Tocilizumab Brain Disorder	Zhujiang Hospital	P3	B (60)
Physiologic Sodium Chloride Solution Brain Disorder	Zhujiang Hospital	P3	B (58)
Dexasone Brain Disorder	Eli Lilly and Company	P3	B (57)
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer Brain Disorder	Charite University, Berlin, Germany	P2	B (57)
Semaglutide Brain Disorder	Chinese University of Hong Kong	P2	B (57)
Tenecteplase Brain Disorder	University of Melbourne	P2/3	B (57)
Apsolol Brain Disorder	Tianjin Medical University General Hospital	P2	CCC (53)
Bevifibatide Citrate Brain Disorder	Zhujiang Hospital	P2	CCC (53)
Ceftriaxone Brain Disorder	Tianjin Medical University General Hospital	P2	CCC (53)
Retigabine Brain Disorder	Xenon Pharmaceuticals Inc.	P3	CCC (53)
Sgm-101 Brain Disorder	Leiden University Medical Center	P2	CCC (53)
Pegipanermin Brain Disorder	Inmune Bio, Inc.	P2	CCC (48)
Abemaciclib Brain Disorder	Stemline Therapeutics, Inc.	P1/2	CC (45)
Elacestrant Brain Disorder	Stemline Therapeutics, Inc.	P1/2	CC (45)
Fluoroethylnormemantine Brain Disorder	ReST Therapeutics	P1	CC (41)
G 207 Brain Disorder	M.D. Anderson Cancer Center	P1	CC (41)
Adrenomedullin Brain Disorder	Danish Headache Center	N/A	D (30)
Amylin Brain Disorder	Danish Headache Center	N/A	D (30)
Carbon Dioxide Brain Disorder	Washington University School of Medicine	N/A	D (30)